GENTAMICIN INJECTION USP 40 MG
GENTAMICIN (GENTAMICIN SULFATE) : 40 MG · DIN 02242652 · SANDOZ CANADA INCORPORATED
Health Canada status: MARKETED
What is GENTAMICIN INJECTION USP?
GENTAMICIN INJECTION USP 40 MG contains GENTAMICIN (GENTAMICIN SULFATE) : 40 MG. It is listed in the Health Canada Drug Product Database under DIN 02242652, held by SANDOZ CANADA INCORPORATED, supplied as SOLUTION for INTRAMUSCULAR ; INTRAVENOUS administration. Health Canada currently lists it as marketed, status dated 18-Aug-2005. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
Product details and regulatory record
| DIN | 02242652 |
|---|---|
| Brand name | GENTAMICIN INJECTION USP |
| Generic / active ingredient | GENTAMICIN (GENTAMICIN SULFATE) : 40 MG |
| Manufacturer | SANDOZ CANADA INCORPORATED |
| Strength | 40 MG |
| Dosage form | SOLUTION |
| Route of administration | INTRAMUSCULAR ; INTRAVENOUS |
| Schedule | Prescription |
| ATC code | J01GB03 GENTAMICIN |
| AHFS class | 08:12.02 |
| Biosimilar | No |
| Health Canada status | MARKETED |
| Status date | 18-Aug-2005 |
| Original market date | 2000-12-20 00:00:00 |
What can be used instead?
Other Canadian products sharing ATC code J01GB03 GENTAMICIN. 6 of 20 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| GENTAMICIN INJECTION USP | 10 MG | SOLUTION | HIKMA CANADA LIMITED | MARKETED | DIN 02470462 |
| GENTAMICIN INJECTION USP | 10 MG | SOLUTION | SANDOZ CANADA INCORPORATED | MARKETED | DIN 02268531 |
| GENTAMICIN INJECTION USP | 40 MG | SOLUTION | HIKMA CANADA LIMITED | MARKETED | DIN 02457008 |
| GENTAMICIN(E) | 1 MG | SOLUTION | BAXTER CORPORATION | MARKETED | DIN 02082136 |
| GENTAMICIN(E) | 1.6 MG | SOLUTION | BAXTER CORPORATION | MARKETED | DIN 02082152 |
| CIDOMYCIN INJ 10MG/ML | 10 MG | LIQUID | HOECHST ROUSSEL CANADA INC. | CANCELLED POST MARKET | DIN 01989707 |
| CIDOMYCIN INJ 40MG/ML | 40 MG | LIQUID | HOECHST ROUSSEL CANADA INC. | CANCELLED POST MARKET | DIN 01989693 |
| CIDOMYCIN INJ 40MG/ML | 40 MG | LIQUID | ROUSSEL CANADA INC. | CANCELLED POST MARKET | DIN 00259179 |
| CIDOMYCIN INJ PEDIATRIC 10MG | 10 MG | LIQUID | ROUSSEL CANADA INC. | CANCELLED POST MARKET | DIN 00259160 |
| GARAMYCIN INJ 10MG/ML PEDIATRIC | 10 MG | SOLUTION | SCHERING-PLOUGH CANADA INC | CANCELLED POST MARKET | DIN 00223832 |
Who else supplies GENTAMICIN worldwide?
Nexara tracks national medicine registries and published price lists across multiple markets. GENTAMICIN appears in 89 registered pack listings across 9 markets, published on 7 different national price bases. Where a Canadian route is closed, that is where an alternative route of supply starts — subject to the import rules in both countries.
Registered listings are not stock. Ask us to confirm what can actually be sourced for your order.
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.